| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $875K | +840.9% | +351.0% |
| R&D Expense | $348K | +521.4% | +329.6% |
| SG&A Expense | $1.5M | -10.3% | +23.5% |
| Operating Income | -$1.0M | +39.8% | +10.8% |
| Net Income | -$976K | -201.2% | -35.0% |
| EPS (Basic) | -$0.30 | -172.7% | -3.4% |
| EPS (Diluted) | -$0.30 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $4.6M | +52.0% | +59.1% |
| Accounts Receivable | $100K | -81.0% | +127.3% |
| Current Assets | $5.1M | +26.0% | +42.8% |
| Total Assets | $10.4M | +11.2% | +17.0% |
| Current Liabilities | $877K | +9.6% | +25.3% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.7M | — | — |
| Financing Cash Flow | $3.1M | — | — |
| -172.7% |
| -3.4% |
| $9.5M |
| +11.3% |
| +16.3% |